APA

Hirano A., Shimizu T., Imamura H., Watanabe O., Kinoshita J., Okabe T., Kimura K., Kamimura M., Domoto K., Aiba M. & Ogawa K. (20060612). The combination of epirubicin plus docetaxel as neoadjuvant chemotherapy in locally-advanced breast cancer. : Anticancer research.

Chicago

Hirano Akira, Shimizu Tadao, Imamura Hiroshi, Watanabe Osamu, Kinoshita Jun, Okabe Toshihiro, Kimura Kiyomi, Kamimura Mari, Domoto Kaoru, Aiba Motohiko and Ogawa Kenji. 20060612. The combination of epirubicin plus docetaxel as neoadjuvant chemotherapy in locally-advanced breast cancer. : Anticancer research.

Harvard

Hirano A., Shimizu T., Imamura H., Watanabe O., Kinoshita J., Okabe T., Kimura K., Kamimura M., Domoto K., Aiba M. and Ogawa K. (20060612). The combination of epirubicin plus docetaxel as neoadjuvant chemotherapy in locally-advanced breast cancer. : Anticancer research.

MLA

Hirano Akira, Shimizu Tadao, Imamura Hiroshi, Watanabe Osamu, Kinoshita Jun, Okabe Toshihiro, Kimura Kiyomi, Kamimura Mari, Domoto Kaoru, Aiba Motohiko and Ogawa Kenji. The combination of epirubicin plus docetaxel as neoadjuvant chemotherapy in locally-advanced breast cancer. : Anticancer research. 20060612.